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Abstract:
This study was undertaken to determine the effects of high fat diet and aldose
reductase deficiency on the structure and function of murine perivascular adipose tissue.
Wild type (WT) (C57 bl/6) and aldose reductase knockout (AR-null) mice were aged to 8
or 18 weeks on a normal chow diet then some were switched to a high fat diet for 4
weeks while others remained on the control diet for the same amount of time. Following
4 weeks, mice were euthanized PVAT was analyzed. High fat feeding significantly
increased body fat percentage in both age groups of mice and the area of PVAT present
around distal thoracic aorta sections also increased. Additionally, WT and AR-null mice
appeared to exhibit an increase in the area of white adipocyte clusters present in PVAT,
although the results were not significant. When examining the area of white adipocytes
present in PVAT, HF feeding significantly increased area of adipocytes throughout
PVAT in WT, 22-week old mice and a significant increase in VAT and overall PVAT,
but not DAT in AR-null mice. To examine the functional properties of PVAT, sections of
aorta with intact and removed PVAT were measured for contraction and relaxation
properties. In WT mice, HF feeding resulted in endothelial dysfunction, seen as a reduced
relaxation response to acetylcholine. The presence of intact PVAT reversed the observed
dysfunction. Collectively, these data suggest that PVAT adiposity is increased similar to
overall adiposity with high fat feeding and that this change is structure may contribute to
the functional changes also observed with high fat feeding.
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Introduction:
Obesity is one of the fastest growing health problems today, nearing pandemic
status worldwide. The United States is perhaps one of the countries most affected, with
roughly one third of the population being obese [2]. A diet composed of high fat and
sugar laden foods and beverages, along with an ever more sedentary lifestyle, has spelled
a recipe for disaster in American citizens. Obesity is particularly prevalent in the Deep
South, where Mississippi and Louisiana have obesity rates of 34.9% and 33.4%,
respectively [3]. With an obesity prevalence of 30.4%, Kentucky is also no stranger to
this “growing” problem [3].
Obesity is associated with an increased risk of developing type-2 diabetes and
cardiovascular disease. This increased cardiovascular risk is associated with increased
visceral adiposity, but not subcutaneous adiposity [4]. However, the mechanisms by
which visceral adiposity affects cardiovascular disease risk are currently unknown. In
recent years, diabetes has also become an increasing problem in the United States. Type2 diabetes occurs when the body either does not respond to insulin, or no longer produces
enough insulin to elicit a response in the body [5]. It is proposed that the release of free
fatty acids from adipocytes blocks insulin-signaling pathways, leading to insulin
resistance [5].
No direct link between visceral adiposity and cardiovascular disease has been
elucidated to date. Because of this, investigations of more local adipose depots has
ensued and the perivascular adipose tissue (PVAT) has become an increasingly popular
topic in cardiovascular research. Found surrounding the adventitial layer of blood vessels,
perivascular adipose exhibits a reduced level of adipocyte differentiation compared to
visceral and subcutaneous adipose depots [6]. In addition, perivascular adipocytes
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possess peculiar properties such as endocrine functions [7], as well as reactivity to
metabolic cues and functioning in signal transduction to blood vessels [8-10]. PVAT
exhibits anti-contractile effects on blood vessels via the release of vasorelaxants such as
adiponectin and yet undiscovered adipose derived relaxing factors (ARDF) [11]. Under
normal physiological conditions, PVAT protects against neointimal hyperplasia
following angioplasty, potentially a result of ADRF and adiponectin secretions [12].
Perivascular adipose is believed to be a key contributor to cardiovascular disease,
particularly atherosclerosis. Magnetic resonance imaging (MRI) studies show that the
quantity of PVAT on human coronary arteries is correlated with hyperglycemia,
hypertriglyceridemia, and coronary atherosclerosis [13]. Additionally, studies where
perivascular adipose has been transplanted to vessels where it is normally absent show
that PVAT contributes to neointimal hyperplasia following intraluminal vascular injury
[14]. It is possible that these deleterious contributions of PVAT are a result of increased
pro-inflammatory cytokine secretion under conditions of obesity [15].
Aldose reductase (AR), a widely expressed aldehyde-metabolizing enzyme,
functions in the reduction of cytotoxic aldehydes such as those formed during lipid
peroxidation [1]. Glucose acts as an incidental substrate to AR because of a very high Km
[1], yet AR-catalyzed metabolism of glucose via the polyol pathway is associated with
secondary diabetic complications, potentially due to accumulation of sorbitol (Scheme I)
[16]. In previous years, inhibition of the AR enzyme has been considered as a possible
therapeutic target for managing type-1 diabetes [17]. Inhibition of AR in type-1 diabetic
models shows favorable effects on vascular diabetic complications such as retinopathy,
neuropathy, nephropathy, and endothelial dysfunction [17]. In type-2 diabetes, however,
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the role of AR in presently unclear because blood glucose does not reach the levels
observed in Type I diabetes models of human disease.

Scheme I: Reactions of Aldose Reductase

Scheme	
  I: Illustration of aldose reductase function of reducing aldehydes to alcohols.
The enzyme’s affinity for glucose is relatively low [1], and at normal blood sugar
levels sorbitol production is minimal. In a type-1 diabetic state, where blood sugar
levels are very high, sorbitol production is much higher. Generation of sorbitol, which
is an osmolyte, to high intracellular levels could increase cell swelling and impair
function.
The objective of this study was to provide an in depth characterization of aortic
perivascular adipose tissue in control diet (CD) and high fat (HF) diet fed mice. Second,
we wanted to investigate the potential role of aldose reductase (AR) in modifying the
response to HF diet because AR deficiency should diminish the ability of the mouse to
deal with enhanced levels of oxidative stress via the reduction of cytoxic aldehydes to
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less reactive alcohols. It has been shown that high fat diet induces endothelial dysfunction
[19], and perivascular adipose may play an important role in this process [11], although
exact mechanisms are not known. The goal of this study is to gain a better understanding
of how diet affects obesity and PVAT structure and function because PVAT may
ultimately contribute to vascular dysfunction and disease [20]. Studies of PVAT have
revolved primarily around white unilocular adipocytes present in this depot that are
shown to increase risk for atherosclerosis and cardiovascular disease [13-15]. Murine
thoracic aorta PVAT is primarily brown multilocular adipose under normal conditions,
and it is considered resistant to inflammation induced by obesity [21]. To test this idea,
we	
  hypothesized	
  that	
  high	
  fat	
  diet	
  feeding	
  will	
  result	
  in	
  an	
  increased	
  PVAT	
  area,	
  as	
  
well	
  as	
  a	
  shift	
  in	
  PVAT	
  composition	
  from	
  a	
  brown	
  adipose	
  phenotype	
  to	
  a	
  white	
  
adipose	
  phenotype.	
  Recent evidence suggests that an accumulation of oxidative stress in
or around the vasculature under obese conditions results in endothelial dysfunction,
diabetes, and an elevated cardiovascular disease risk [22]. Because AR can convert
cytotoxic aldehydes to alcohols [1], and thus, decrease products of oxidative stress, we
hypothesized that mice genetically deficient of AR (AR-null mice [23]) would be more
susceptible to diet-induced obesity, exhibiting increased adiposity and vascular functional
complications associated with obese conditions.

Objectives:
1) To determine if PVAT adiposity is increased under high fat diet feeding
conditions, as is overall adiposity;
2) To examine the effects of high fat diet on functional properties of PVAT in
isolated aorta; and,
3) To assess whether genetic deletion of AR affects obesity and PVAT structure and
function under control and high fat diet feeding conditions.
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Materials & Methods:
Mice. For this study, young male wild type (WT) (C57Bl/6J; Jackson Laboratory, Bar
Harbor, MA) and aldose reductase-null (AR-null) mice bred on a C57Bl/6 background
[23] were maintained in a temperature-controlled room (22oC) on a 12:12 hr light: dark
cycle and fed a normal chow (NC) diet composed of 59% kcal from carbohydrates, 29%
kcal from protein, and 12% kcal from fat (LabDiet 5010, PMI Nutrition, St. Louis, MO)
after weaning. At 8- or 18-weeks old, mice were either maintained on NC diet or
switched to a high fat (HF) diet composed of 60% kcal from fat (lard-based), 20% kcal
from protein, and 20% kcal from carbohydrates (D12492, Research Diets INC, New
Brunswick, NJ) for 4 weeks.
Fat Composition: Body lean and fat masses were analyzed and their percentages
calculated using dual energy x-ray absorptiometry (DEXA) scans using a Lunar PIXImus
(GE Healthcare, Waukesha, WI) bone density scanner following sodium pentobarbital
injection (0.15-0.3 mL, Sigma-Aldrich, St. Louis, MO). The composition of mouse head
(majority bone) was excluded from all measurements (Fig. 1A).
Aorta Reactivity: Following DEXA scan, the thoracic aorta was isolated and 2 adjacent
segments (≈4mm) were prepared. The PVAT was carefully cleaned from 1 segment and
left intact on the other segment. Each aortic segment was placed on stainless steel hooks
in phosphate-buffered solution. Aortas were equilibrated to 1g tension, contracted 2
separate times with high potassium (100 mM K+; +3 washes), phenylephrine challenged
(PE; 0.1 nM-30 µM), and exposed to acetylcholine (ACh; 0.1 nM-30 µM). After 3
washes, aortas were contracted with thromboxane A2 analog (U46619) and relaxed with
sodium nitroprusside (SNP; 0.1 nM-10 µM)[24].
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Scheme II: Aortic Section Removal

1.2 cm	
  
4mm	
  
	
  

Mountsinai.org

Scheme	
   II: Illustration of aorta indicating location of distal thoracic aorta where
segments were removed for study. Inset: Short segments (4mm length) were obtained
from the distal thoracic aorta. Aortic sections were fixed in 10% neutral buffered
formalin for aortic reactivity and PVAT morphometric analysis.
Histology: A 4 mm length of aorta was obtained from the distal thoracic aorta (Scheme
II). Aortic sections were placed in processing cassettes and fixed in 10% neutral buffered
formalin (Leica Microsystems; Wetzlar, Germany). Histopathology was performed on
formalin-fixed, paraffin-embedded aortic cross sections (5 μM) stained with hematoxylin
and eosin (H&E) or fast green/Sirius red. Images were obtained at ≈100x magnification
using a Spot advanced image capture software (SPOT Imaging Solutions, Sterling
Heights, MI).
PVAT Morphometry:
Dorsal and Ventral Adipose Tissue: Perivascular adipose tissue (PVAT) is divided into
ventral adipose tissue (VAT) and dorsal adipose tissue (DAT) sections (Scheme 3). All
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area measurements were obtained using IMAGEJ. These measurements were performed
by outlining the outer edge of the VAT using IMAGEJ drawing tools, tracing the
adventitia-VAT border, and completing a loop around the VAT. DAT measurements
were similarly performed by outlining the outer edge of the DAT using IMAGEJ drawing
tools, tracing the DAT-adventitia border, and completing the loop around the DAT. Scale
calibration was performed using a scale calibrated to the image and magnification by spot
software to obtain absolute measurements.

Scheme III: Dorsal and Ventral Adipose Defined

Dorsal	
  Adipose	
  
Tissue
	
  

Ventral	
  Adipose	
  
Tissue

	
  

Scheme	
   III: Low power micrograph of H&E stained aortic cross section
with defined areas of dorsal (DAT; green) and ventral adipose tissue
(VAT; yellow) Mag.=4x.
Adipocyte Measurements: White adipocyte clusters were measured from the cross
sections using NIH free software IMAGEJ (version 1.45s). Areas of clusters found in
both the DAT and VAT were measured using IMAGEJ drawing tools. These clusters
were defined as having ≥5 adjacent white (unilocular) adipocytes (Scheme III). These
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clusters were typically found on the periphery of PVAT and usually surrounding blood
vessels (vasa vasorum) near the aorta adventitia. The area of individual adipocytes
present in these clusters was also measured using IMAGEJ drawing tools, and number of
adipocytes in each cluster was manually counted.

Figure 1: White Adipocyte Clusters

Figure	
   1: Low power micrograph of H&E stained aortic cross section from a 22week-old AR-null mouse. Inset: Higher power image showing white adipocyte
cluster present on the periphery of PVAT. Mag. =4x; inset: Mag.= 40x
Statistics: Values are mean + S.E.M. Group data were compared using t test, one-way
analysis of variance with Holm-Sidak or Bonferroni post-test, or Kruskal-Wallis analysis
of variance by ranks with Dunn’s post test where appropriate (SigmaStat; SPSS, Inc.,
Chicago, IL). Significance level was set at p<0.05.

Results:
DEXA Scan: High fat diet feeding significantly increased the percentage of fat measured
using DEXA scan of both WT and AR-null mice (Fig.1). The largest gains were seen in
the 22-week old WT (39.2% + 1.7%) and AR-null (45.9% + 1.0%) mice, there was no
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difference in body fat percentage between NC 12-week and NC 22-week old animals in
both groups (Fig. 1 A). When comparing 12-week old AR-null and WT mice on NC, ARnull mice had a significantly greater percentage fat than their WT counterparts (Fig. 1). A
significant difference in fat percentage was also noted between 12-week old WT and ARnull mice fed HFD for 4 weeks. Additionally, a significant difference in body fat
percentage was observed in comparisons between NC and HF 22-week old WT and ARnull mice.
PVAT Ring Analysis: Analysis of PVAT on fixed aortas revealed a significant increase
in ring PVAT (mg/mm) in HF 12-week old AR-null mice when compared to the NC 12week old AR-null group (Fig.1 B). High fat diet also appeared to increase ring PVAT
(mg/mm) in WT and AR-null 22-week old mice, but the increase was not significant.
PVAT Area Measurements: PVAT area was measured using IMAGEJ. In WT mice,
high fat feeding appeared to increase the area of DAT and total PVAT in both 12 and 22week old animals, however the data was not significant. In AR-null mice, DAT area
appeared to increase with high fat feeding in both 12 week and 22-week-old mice. VAT
area also increased with high fat diet, and there was a significant increase observed in HF
22-week old mice when compared to NC mice of the same age and genotype. When
examining the entirety of the Perivascular adipose tissue (PVAT), area appeared to
increase with high fat feeding, although the observed differences were not statistically
significant.
White Adipocyte Cluster Analysis: In WT mice, HF feeding appeared to increase the
cluster area in both the 12 and 22-week old groups. The greatest increase in cluster area
was seen in the HF 22-week old group; however, none of these increases were
determined to be significant (Fig.4 A). This could be attributed to the high variation of
	
  

12	
  

cluster area found in the HF animal groups. In AR-null mice, HF feeding appeared to
increase cluster area as well, and cluster area in VAT also appeared to increase with age.
Due to high variation in cluster size, there was no significant difference found between
the groups. When comparing WT and AR-null groups, it appeared that AR-null mice had
larger cluster areas initially and gained more cluster area than WT mice when fed a high
fat diet. Particularly high variation was observed in the AR-null mice, which had the
greatest cluster area gains under HF feeding found in their VAT. DAT cluster area
appeared to decrease with age in AR-null mice, and HF diet had no effect to enlarge DAT
clusters (Fig.4 B).
White Adipocyte Area Analysis: The area of individual white adipocytes in PVAT was
measured using IMAGEJ. In WT mice, HF diet increased the area of white adipocytes in
both the DAT and VAT. Of the WT mice, the largest increase in area was seen in the HF
22-week old group. DAT adipocytes in these mice had a significantly greater area than
those of NC 22-week old WT mice. HF feeding also appeared to increase DAT adipocyte
area in the HF 12-week old group, but a significant increase over NC 12-week old mice
was not observed (Fig.4).
WT murine VAT adipocyte area was also increased by HF feeding. Twenty-twoweek old HF mice were seen to have significantly larger adipocytes in VAT than NC 22week old WT mice. Twelve-week-old HF fed mice also appeared to have larger
adipocytes, although the data were not statistically significant. PVAT adipocytes
altogether were increased in area by HF feeding. This increase was seen to be the greatest
in the 22-week-old HF mice, whose adipocytes were significantly larger than those of NC
22-week-old WT mice (Fig.4).
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AR-null adipocyte size changes under HF diet were different than those seen in
WT mice. HF feeding resulted in very little change in DAT adipocyte area of HF 12week old mice, and a slight increase in DAT adipocyte area in HF 22-week old mice. The
greatest increase in adipocyte area under HF feeding was seen in VAT, particularly in 22week old HF mice. These mice showed significantly larger VAT adipocyte area
compared to NC 22-week old AR-null mice. There appeared to be an increase in
adipocyte area in VAT of HF 12-week old mice, but the data were not significant. No
significant increase in DAT adipocyte area accompanied the VAT adipocyte area
increase. Additionally, the mean area of adipocytes present in total PVAT was also
significantly increased in 22-week old HF AR-null mice when compared to NC mice of
the same age and genotype.
White Adipocyte Numbers: Total number of white adipocytes was enumerated from
microscopy images. In WT mice, HF feeding appeared to have an effect to increase the
number of adipocytes in both the 12 and 22-week old groups. Twelve-week old HF mice
appeared to have an increase in mean VAT adipocyte number, as well as an increase in
mean adipocyte number overall. Twenty-two week old HF mice had increased total
adipocyte number overall, as well as in both DAT and VAT individually, however, these
increases were not significant (Fig.5).
In AR-null mice, HF feeding appeared to have a different effect. Both 12- and 22week old HF mice appeared to have a decrease in mean adipocyte number in DAT, VAT,
and overall. This difference appeared larger in the HF 12-week old group. However, the
difference between the groups was not significant (Fig. 6).
When comparing diet and aged matched AR-null and WT mice, AR deficiency appeared
to increase the number of cluster adipocytes in NC fed mice. Significantly more
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adipocytes were observed in VAT of 22-week old NC; AR-null mice when compared to
WT mice of the same age and diet. Under HF conditions, AR-null mice had fewer cluster
adipocytes than their WT counterparts, although no significant differences were
observed.
Aorta Contractility Analysis: Aortas that were not cleaned of PVAT showed increased
high potassium (HI K+) contractility when compared to aortas that were cleaned of
PVAT. Significant increases in contractility were seen in WT NC mice, as well as ARnull NC and HF mice (Fig.6A). In contrast, when aortas were contracted with a
thromboxane A2 analog (U46619), PVAT presence significantly inhibited contractions in
WT HF fed mice and both NC and HF AR-null mice (Fig. 6B). PVAT also exhibited an
effect on acetylcholine (ACh) induced aortic relaxation (Fig. 6C). Intact PVAT on the
WT HF fed group reversed endothelial dysfunction that was observed when the PVAT
was removed from the WT HF aorta. In AR-null mice, ACh-induced relaxation was
significantly enhanced in the HF fed group. Finally, sodium nitroprusside (SNP)
relaxation appeared also to be enhanced by the presence of PVAT on aorta of NC and HF
fed mice in both WT and AR-null groups (Fig. 6D)[24].
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Figure 2: Total Body Fat and PVAT Ring Analysis
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Figure 2: High fat diet increases the percent body fat of both AR-null and WT mice. Shown
are graphs of mean percent body fat (A) of all groups, PVAT ring analysis (B), and a
regression of PVAT vs. % body fat (C). Percent body fat was measured using DEXA-scan. *
Indicates the data were significantly different than other within the group, and # indicates
the data is significantly different than the age and diet matched member of the other group
(p<0.05).
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Figure 3: PVAT Area Analysis
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Figure 2: High fat diet affects size of PVAT. Graphs show WT (A) and AR-null (B) mean
2
area (µm ) of DAT, VAT, and total PVAT. * Indicates the data are significantly different than
age and genotype matched mice (p<0.05). ARKO: NC 12-weeks n=6; HF 12-weeks n=4;
NC 22-weeks n=5; HF 22-weeks n=8. WT: NC 12-weeks n=5; HF 12-weeks n=7; NC 22weeks n=4; HF 22-weeks n=4.
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Figure 4:White Adipocyte Cluster Analysis
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Figure 4: High fat diet effects on white adipocyte cluster area. Graphs show WT (A) and
2
AR-null (B) mean area (µm ) of DAT, VAT, and total PVAT adipocyte clusters. ARKO: NC
12-weeks n=6; HF 12-weeks n=4; NC 22-weeks n=5; HF 22-weeks n=8. WT: NC 12-weeks
n=5; HF 12-weeks n=7; NC 22-weeks n=4; HF 22-weeks n=4.
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Figure 5: White Adipocyte Area Analysis
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Figure 5: High fat diet effects on adipocyte area. Graphs show WT (A) and AR-null (B)
2
mean area (µm ) of DAT adipocytes, VAT adipocytes, and total PVAT adipocytes. *
Indicates the data are significantly different than genotype and age matched mice of
differing diets (p<0.05). ARKO: NC 12-weeks n=6; HF 12-weeks n=4; NC 22-weeks n=5;
HF 22-weeks n=8. WT: NC 12-weeks n=5; HF 12-weeks n=7; NC 22-weeks n=4; HF 22weeks n=4.
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Figure 6: Cluster Adipocyte Enumeration
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Figure 6: High fat diet effects on adipocyte number. Graphs show WT and AR-null mean
number of adipocytes in DAT, VAT, and total PVAT slides. † Indicates the data are
significantly greater than diet and age matched mice of differing genotypes (p<0.05).
ARKO: NC 12-weeks n=6; HF 12-weeks n=4; NC 22-weeks n=5; HF 22-weeks n=8. WT:
NC 12-weeks n=5; HF 12-weeks n=7; NC 22-weeks n=4; HF 22-weeks n=4.	
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Figure 7: Aortic Reactivity Analysis
A
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Figure 6: High potassium-induced contractions in WT and ARKO mice (A). PVAT increased
HI K+ contractility is increased in aortas with PVAT intact (NC+, HFD+) compared to aortas
devoid of PVAT (NC-, HFD-). PVAT is enhancing contractility in response to high potassium
(A). Thromboxane A2 agonist contractions in WT and ARKO mice (B). In both groups,
presence of PVAT (+) significantly inhibited U46619-induced contraction (B). Acetylcholineinduced aortic relaxation in WT and ARKO mice (C). Where PVAT was intact in the WT
HFD-fed group (HFD+), endothelial dysfunction (HFD-) was reversed. In ARKO mice, PVAT
in HFD group (HFD+) significantly enhanced ACh-induced relaxation over HFD- (C). SNPinduced aortic relaxation in WT and ARKO mice (D). PVAT enhanced SNP-induced
relaxation (as %) in both NC and HFD fed WT and ARKO mice (D). N=4 for all groups
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Discussion:
This study demonstrates for the first time that short-term high fat feeding results
Under high fat feeding conditions, body fat percentage significantly increased in all
groups, as expected. AR-null mice had a higher percent body fat that their diet and age
matched WT counterpart. It is of interesting note that while AR-null mice had an
accelerated obesity level of WT mice, they did not exhibit endothelial dysfunction, as
was observed in WT HF fed mice. Additionally, PVAT mass also appeared to increase
with HF feeding, with a greater increase in mass occurring in AR-null mice. These results
indicate that increases in PVAT adiposity mirror overall body adiposity.
In addition to an increase in the mass of PVAT, area was also increased under
high fat feeding conditions. The greatest gains in area appeared to be in DAT, although a
relatively high variance led to a lack of statistical significance for these measurements.
AR-null mice appeared to have a greater PVAT area when compared to WT age and diet
matched counterparts, suggesting that AR plays a role in proliferation/growth of adipose
depots. DAT is more vascularized than VAT, and because this is where the greatest
amount of growth occurs a likely explanation for this growth would be the infiltration of
adipose stem cells, likely to be unique to PVAT [7, 25].
The area of white adipocyte clusters was highly variable in this study. In ARnull mice, HF feeding appeared to increase cluster area in VAT, while cluster area in
DAT remained the same. A similar effect was seen as AR-null mice aged, independent of
diet. While these trends in AR-null mice were not significant, further study may find that
VAT white adipocyte clusters are larger than others. White adipocyte cluster areas of WT
mice were also highly variable through this study, but weak trends can be noticed from
the data. Overall, HF diet appeared to increase the area of white adipocyte clusters
	
  

22	
  

throughout the PVAT. It appeared that a majority of these clusters occur on the periphery
of PVAT or adjacent to a blood vessel. From these observations, it is possible that white
PVAT adipocyte stem cells are entering through the bloodstream or that the primarily
brown multilocular adipose of PVAT differentiates to a white unilocular phenotype under
high fat conditions.
Overall white adipocyte size appeared to increase with high fat feeding. In WT
mice area increase was uniform across the entirety of PVAT with both DAT and VAT
white adipocytes increasing similarly in area. AR-null mice showed a greater increase in
adipocyte area in the VAT region of PVAT than in DAT. Mice aged 22 weeks showed
larger gains in adipocyte size under HF conditions than 12 week-old, suggesting that age
plays a role in the size increase of these cells. Additionally, AR may also be important in
the localization/ growth of these larger adipocytes.
When examining the numbers of white adipocytes present in clusters, WT mice
increased the number of white adipocytes present in clusters. Interestingly, it appears that
HF fed mice of AR-null groups have a lower number of cluster adipocytes than NC mice.
This lower number might be important in the compensatory effects of PVAT under HF
conditions. Studies of white unilocular PVAT show that it expresses high levels of
inflammatory cytokines [6] and dispersal of these white adipocytes throughout the brown
PVAT may diminish the ability to elicit an inflammatory response. Due to the high
variability observed in enumeration, however, these results should be cautiously
interpreted.
Following high fat feeding, aortas from WT mice aged 22 weeks exhibited
endothelial dysfunction that was detected as a decreased relaxation response to ACh.
When PVAT was left on the aorta, endothelial dysfunction was no longer detected. These
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results support the idea that PVAT plays an important role in vascular function.
Additionally, they suggest that perivascular adipose may be playing a part in the
maintenance of normal function under adverse physiological conditions.
Functional analysis of both WT and AR-null aortas revealed that the presence of
PVAT modifies aortic response to several different vasoactive compounds in a similar
way. Aortas with PVAT present showed a weaker contraction when exposed to a
thromboxane A2 agonist. This response to the thromboxane agonist likely demonstrates
the action of adipose derived relaxing factors. These ARDFs are proposed to act on
voltage dependent K+ channels in the membrane of vascular smooth muscle cells,
resulting in hyperpolarization [26]. This idea is further supported by the increased high
potassium contractility of PVAT positive aortas. The increase in external K+ levels result
in a reduced difference between K+ equilibrium potential and the electric potential of the
membrane, which diminishes any effect a K+ channel opener would exhibit [9].
Perivascular adipose presence appears to enhance the relaxation of mouse
aortas under high fat feeding conditions. In this study, HF fed WT mouse aortas
developed endothelial dysfunction, which presented as a diminished ACh relaxation.
When PVAT was left on these aortas, endothelial dysfunction was reversed. These results
suggest that PVAT is exhibiting a compensatory effect on the aorta under adverse
physiological conditions, in this case high fat feeding and obesity. This could be a result
of an increased action/expression of ADRFs, but further studies would need to be
conducted to test this explanation. When examining SNP-induced relaxation, PVAT
positive aortas from both NC and HF animals appeared to have responded with a greater
amount of relaxation, although there was no significant difference in the data. Again, this
is potentially the result of ADRF action on the aorta.
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There are several limitations that should be noted in this study. First, a small
number of animals were used for each group and because of this, our results may not
accurately reflect what occurs in the population under these experimental conditions.
Additionally, only male mice were used in this study, but this is due to the fact that males
are more susceptible to cardiovascular disease than females. While most current PVAT
research explores its detrimental properties, this study demonstrates that PVAT in an
important tissue that is still very much a mystery. Studies of white PVAT have revealed it
to be inflammatory in nature and its size is correlated to cardiovascular disease risk [6,
13]. Conversely, in our present study we focused on the brown adipose of PVAT and
functional data reveal that offers compensatory benefits under short-term high fat diet
stress. Under long-term high fat diet, PVAT may eventually lose its compensatory
benefits and become increasingly inflammatory, reducing its ability to release ARDFs
and raising the risk for cardiovascular problems via the release of contractile factors.
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